Cargando…

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis

Kirsten rat sarcoma viral oncogene homolog (KRAS) gene encodes a GTPase that acts as a molecular switch for intracellular signal transduction, promoting cell growth and proliferation. Mutations in the KRAS gene represent important biomarkers for NSCLC targeted therapy. However, detection of KRAS mut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmieri, Maria, Zulato, Elisabetta, Wahl, Sissel Gyrid Freim, Guibert, Nicolas, Frullanti, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640997/ https://www.ncbi.nlm.nih.gov/pubmed/36386815 http://dx.doi.org/10.3389/fgene.2022.1015161

Ejemplares similares

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

The undifferentiated carcinoma that became a melanoma: Re-biopsy of a cancer of an unknown primary site: a case report
por: Røe, Oluf Dimitri, et al.
Publicado: (2017)

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer
por: Tøndell, Anders, et al.
Publicado: (2019)

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions
por: Tøndell, Anders, et al.
Publicado: (2021)

Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
por: Nilssen, Yngvar, et al.
Publicado: (2023)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
por: Xie, Wenli, et al.
Publicado: (2019)

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era
por: Palmieri, Maria, et al.
Publicado: (2023)

Identification of exercise‐regulated genes in mice exposed to cigarette smoke
por: Aakerøy, Lars, et al.
Publicado: (2022)

Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients
por: Boldrin, Elisa, et al.
Publicado: (2019)

Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors
por: Serio, Viola Bianca, et al.
Publicado: (2023)

Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
por: Jiang, Lin, et al.
Publicado: (2021)

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
por: Zocche, David M., et al.
Publicado: (2015)

The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer
por: Zhang, Jisong, et al.
Publicado: (2020)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors
por: Nardo, Giorgia, et al.
Publicado: (2021)

Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy
por: Zhou, Yidong, et al.
Publicado: (2016)

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
por: Birkeland, E, et al.
Publicado: (2012)

Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
por: Morgan, Shethah R., et al.
Publicado: (2012)

KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control
por: Le Calvez-Kelm, Florence, et al.
Publicado: (2016)

Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
por: Hou, Jinpao, et al.
Publicado: (2016)

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2009)

Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum
por: Matsubara, A, et al.
Publicado: (2015)

COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma
por: Pritchard, Colin C, et al.
Publicado: (2010)

Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
por: Zulato, Elisabetta, et al.
Publicado: (2020)

Utility of KRAS mutation detection using circulating cell‐free DNA from patients with colorectal cancer
por: Yamada, Takeshi, et al.
Publicado: (2016)

Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
por: Rahat, Beenish, et al.
Publicado: (2020)

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
por: Phipps, A I, et al.
Publicado: (2013)

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations
por: Liu, Xiaojun, et al.
Publicado: (2020)

Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations
por: Silverwood, Sierra M, et al.
Publicado: (2022)

Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis
por: Liu, Yue-Ping, et al.
Publicado: (2014)

The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis
por: Ye, Peng, et al.
Publicado: (2021)

KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers
por: Zhao, Da, et al.
Publicado: (2022)

KRAS G12C-Mutant Non-Small-Cell Lung Adenocarcinoma: First Documented Report in the Arabian Gulf
por: Alsulaiman, Abdullah S, et al.
Publicado: (2022)

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer
por: Gao, Liyuan, et al.
Publicado: (2022)

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021)

Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
por: Barefoot, Megan E., et al.
Publicado: (2021)

Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA
por: Pisareva, Ekaterina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ui65gi22a2vfh17eqesddp4ttn